Abstract: Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and asymptomatic left ventricular dysfunction.
Type:
Grant
Filed:
June 10, 2013
Date of Patent:
July 15, 2014
Assignees:
University of Kanasas, Silvergate Pharmaceuticals, Inc.
Inventors:
Lian G. Rajewski, Roger A. Rajewski, John L. Haslam, Kathleen Heppert, Michael C. Beckloff, Frank Segrave, Robert Mauro, Peter Colabuono